RenaissanceRe - RNR Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $290.09
  • Forecasted Upside: 16.33%
  • Number of Analysts: 12
  • Breakdown:
  • 1 Sell Ratings
  • 6 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$249.37
▲ +1 (0.40%)

This chart shows the closing price for RNR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RenaissanceRe Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RNR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RNR

Analyst Price Target is $290.09
▲ +16.33% Upside Potential
This price target is based on 12 analysts offering 12 month price targets for RenaissanceRe in the last 3 months. The average price target is $290.09, with a high forecast of $391.00 and a low forecast of $240.00. The average price target represents a 16.33% upside from the last price of $249.37.

This chart shows the closing price for RNR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 12 contributing investment analysts is to hold stock in RenaissanceRe. This rating has held steady since November 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
6/29/2023
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 1 sell ratings
9/27/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 1 hold ratings
  • 2 sell ratings
12/26/2023
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 2 sell ratings
3/25/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/23/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/21/2024
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 1 sell ratings
11/20/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/18/2024Jefferies Financial GroupReiterated RatingBuy ➝ Hold$304.00 ➝ $282.00
11/12/2024Keefe, Bruyette & WoodsLower TargetOutperform ➝ Outperform$316.00 ➝ $310.00
11/7/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$274.00 ➝ $280.00
11/7/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$229.00 ➝ $246.00
10/10/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$267.00 ➝ $274.00
10/10/2024Bank of AmericaBoost TargetBuy ➝ Buy$364.00 ➝ $391.00
10/10/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$280.00 ➝ $314.00
10/9/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$270.00 ➝ $314.00
10/9/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$218.00 ➝ $229.00
9/10/2024CitigroupBoost TargetBuy ➝ Buy$262.00 ➝ $298.00
9/4/2024BarclaysInitiated CoverageEqual Weight$287.00
7/26/2024Wells Fargo & CompanyLower TargetOverweight ➝ Overweight$288.00 ➝ $280.00
7/25/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$265.00 ➝ $267.00
7/11/2024Bank of AmericaBoost TargetBuy ➝ Buy$334.00 ➝ $347.00
7/11/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$245.00 ➝ $265.00
7/10/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$257.00 ➝ $240.00
7/9/2024UBS GroupLower TargetNeutral ➝ Neutral$251.00 ➝ $248.00
5/1/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$237.00 ➝ $245.00
5/1/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$216.00 ➝ $218.00
4/11/2024Evercore ISIBoost TargetUnderperform ➝ Underperform$213.00 ➝ $216.00
4/8/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$204.00 ➝ $237.00
2/5/2024UBS GroupBoost TargetNeutral ➝ Neutral$229.00 ➝ $238.00
2/5/2024BMO Capital MarketsBoost TargetOutperform ➝ Outperform$216.00 ➝ $295.00
1/10/2024TD CowenInitiated CoverageMarket Perform
12/14/2023Evercore ISIInitiated CoverageUnderperform$200.00
11/22/2023CitigroupInitiated CoverageBuy$251.00
10/11/2023Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$229.00 ➝ $240.00
10/6/2023Jefferies Financial GroupLower Target$249.00 ➝ $246.00
9/8/2023The Goldman Sachs GroupInitiated CoverageBuy$242.00
8/21/2023Bank of AmericaLower TargetBuy ➝ Buy$275.00 ➝ $266.00
7/11/2023BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$198.00 ➝ $216.00
6/20/2023Morgan StanleyInitiated CoverageEqual Weight$222.00
5/25/2023Jefferies Financial GroupUpgradeHold ➝ Buy$234.00 ➝ $238.00
4/10/2023Jefferies Financial GroupBoost TargetHold$215.00 ➝ $221.00
4/5/2023Wells Fargo & CompanyBoost TargetOverweight$245.00 ➝ $256.00
3/31/2023JPMorgan Chase & Co.Boost TargetUnderweight$170.00 ➝ $175.00
2/2/2023Wells Fargo & CompanyBoost TargetOverweight$234.00 ➝ $245.00
1/19/2023BMO Capital MarketsInitiated CoverageMarket Perform$187.00
1/18/2023Wells Fargo & CompanyBoost TargetOverweight$200.00 ➝ $234.00
11/29/2022Wells Fargo & CompanyBoost TargetOverweight$184.00 ➝ $200.00
11/22/2022Morgan StanleyBoost TargetEqual Weight$150.00 ➝ $195.00
11/3/2022Wells Fargo & CompanyBoost Target$171.00 ➝ $184.00
10/12/2022Wells Fargo & CompanyBoost TargetOverweight$169.00 ➝ $171.00
8/19/2022Morgan StanleyLower TargetEqual Weight$162.00 ➝ $150.00
7/12/2022Jefferies Financial GroupDowngradeBuy ➝ Hold$173.00 ➝ $162.00
5/23/2022Morgan StanleyLower TargetEqual Weight$175.00 ➝ $162.00
2/23/2022Morgan StanleyBoost TargetEqual Weight$172.00 ➝ $175.00
11/19/2021Morgan StanleyBoost TargetEqual Weight$158.00 ➝ $172.00
11/18/2021Jefferies Financial GroupInitiated CoverageBuy$192.00
11/8/2021Bank of AmericaUpgradeNeutral ➝ Buy$163.00 ➝ $218.00
10/29/2021Morgan StanleyLower TargetEqual Weight$166.00 ➝ $158.00
10/15/2021Morgan StanleyLower TargetEqual Weight$182.00 ➝ $166.00
8/16/2021Morgan StanleyBoost TargetEqual Weight$179.00 ➝ $182.00
4/16/2021Morgan StanleyLower TargetEqual Weight$195.00 ➝ $191.00
3/24/2021Morgan StanleyBoost TargetEqual Weight$194.00 ➝ $195.00
1/29/2021Morgan StanleyLower TargetEqual Weight$199.00 ➝ $194.00
1/28/2021Wells Fargo & CompanyLower TargetOverweight$229.00 ➝ $220.00
1/12/2021Morgan StanleyBoost TargetEqual Weight$196.00 ➝ $199.00
1/8/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy$194.00 ➝ $199.00
1/4/2021JPMorgan Chase & Co.Boost TargetUnderweight$160.00 ➝ $162.00
11/24/2020Morgan StanleyBoost TargetEqual Weight$181.00 ➝ $196.00
10/30/2020Morgan StanleyLower TargetEqual Weight$194.00 ➝ $181.00
10/29/2020Deutsche Bank AktiengesellschaftLower TargetHold$192.00 ➝ $186.00
10/19/2020Morgan StanleyLower TargetEqual Weight$205.00 ➝ $194.00
8/19/2020Morgan StanleyLower TargetEqual Weight$220.00 ➝ $205.00
7/31/2020Morgan StanleyBoost TargetEqual Weight$205.00 ➝ $220.00
6/5/2020Morgan StanleyBoost TargetEqual Weight$190.00 ➝ $205.00
6/4/2020Wells Fargo & CompanyBoost TargetOverweight$190.00 ➝ $229.00
5/18/2020Morgan StanleyBoost TargetEqual Weight$182.00 ➝ $190.00
5/15/2020Deutsche Bank AktiengesellschaftLower TargetHold$195.00 ➝ $185.00
5/11/2020Morgan StanleyLower TargetEqual Weight$189.00 ➝ $182.00
4/21/2020CitigroupLower TargetNeutral$192.00 ➝ $158.00
4/14/2020Deutsche Bank AktiengesellschaftBoost TargetHold$190.00 ➝ $195.00
4/1/2020Wells Fargo & CompanyLower TargetOverweight$223.00 ➝ $195.00
4/1/2020Morgan StanleyLower TargetEqual Weight$202.00 ➝ $189.00
2/7/2020Morgan StanleyBoost TargetEqual Weight$188.00 ➝ $202.00
2/6/2020Wells Fargo & CompanyReiterated RatingBuy$223.00
1/22/2020Buckingham ResearchBoost TargetBuy$192.00 ➝ $200.00
1/21/2020CitigroupInitiated CoverageNeutral$192.00
1/7/2020BarclaysReiterated RatingSell$190.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.34 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 24 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2024
  • 18 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2024
  • 15 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 11 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/23/2024
  • 19 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2024
  • 19 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/22/2024
  • 19 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/21/2024
  • 37 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/21/2024

Current Sentiment

  • 37 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
RenaissanceRe logo
RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance and excess of loss reinsurance to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, cyber, energy, marine, satellite, and terrorism. It distributes products and services primarily through intermediaries. The company invests in and manages funds. RenaissanceRe Holdings Ltd. was founded in 1993 and is headquartered in Pembroke, Bermuda.
Read More

Today's Range

Now: $249.37
Low: $247.45
High: $253.81

50 Day Range

MA: $271.08
Low: $241.97
High: $287.47

52 Week Range

Now: $249.37
Low: $190.89
High: $300.00

Volume

1,216,161 shs

Average Volume

370,123 shs

Market Capitalization

$12.95 billion

P/E Ratio

3.59

Dividend Yield

0.64%

Beta

0.41

Frequently Asked Questions

What sell-side analysts currently cover shares of RenaissanceRe?

The following Wall Street sell-side analysts have issued research reports on RenaissanceRe in the last twelve months: Bank of America Co., Barclays PLC, BMO Capital Markets, Citigroup Inc., Evercore ISI, Jefferies Financial Group Inc., JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, StockNews.com, TD Cowen, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for RNR.

What is the current price target for RenaissanceRe?

0 Wall Street analysts have set twelve-month price targets for RenaissanceRe in the last year. Their average twelve-month price target is $290.09, suggesting a possible upside of 16.3%. Bank of America Co. has the highest price target set, predicting RNR will reach $391.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $240.00 for RenaissanceRe in the next year.
View the latest price targets for RNR.

What is the current consensus analyst rating for RenaissanceRe?

RenaissanceRe currently has 1 sell rating, 6 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in RNR, but not buy more shares or sell existing shares.
View the latest ratings for RNR.

What other companies compete with RenaissanceRe?

How do I contact RenaissanceRe's investor relations team?

RenaissanceRe's physical mailing address is RENAISSANCE HOUSE 12 CROW LANE, PEMBROKE D0, HM 19. The insurance provider's listed phone number is (441) 295-4513 and its investor relations email address is [email protected]. The official website for RenaissanceRe is www.renre.com. Learn More about contacing RenaissanceRe investor relations.